Healthcare Equipment and Supplies
Company Overview of CardiacAssist, Inc.
CardiacAssist, Inc. operates as a medical device company that develops, manufactures, and markets novel medical devices to cardiologists and cardiac surgeons for improving the lives of heart failure patients worldwide. The company offers a temporary ventricular assist/circulatory support device for postcardiotomy cardiac failure issues; and TandemLung oxygenator, a medical device that acts as an artificial lung to infuse oxygen and remove carbon dioxide from the blood. It also provides a hydrodynamic centrifugal pump and a transseptal cannula for temporary left ventricular assist needs; and an electromechanical system. CardiacAssist, Inc. was formerly known as Cardiac Assist Technologies, In...
240 Alpha Drive
Pittsburgh, PA 15238
Founded in 1996
Key Executives for CardiacAssist, Inc.
Chairman, Chief Executive Officer and President
Director of Clinical Education
Compensation as of Fiscal Year 2016.
CardiacAssist, Inc. Key Developments
CardiacAssist Receives FDA 510(k) Clearance for its TandemLung Oxygenator
Mar 15 16
CardiacAssist, Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its new TandemLung® oxygenator, a medical device that acts as an artificial lung to infuse oxygen and remove carbon dioxide from the blood. When paired with CardiacAssist's TandemHeart® blood pump, the TandemLung represents a leap forward in extracorporeal life support (ECLS) technology for patients in need of critical cardiopulmonary care. Every year in North America, more than 300,000 patients experience an acute cardiac or respiratory event that requires emergency intervention. However, historically only a small percentage of these patients have received advanced life support utilizing products like the TandemHeart and TandemLung, primarily due to the complexity of deploying existing technology to perform such procedures. The TandemLung oxygenator was developed to make ECLS faster and more accessible with a design optimized for simplicity and performance. Its low priming volume and patent-protected radial flow technology allow the device to be deployed quickly to protect patients from the negative effects of diminished cardiac or respiratory function.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries